Pfizer (PFE) 10-K Summary — Year Ended Dec 31, 2024
Pfizer Inc. filed its annual report describing a business focused on discovering, developing, and commercializing medicines and vaccines. The filing reports a revenue increase compared to the prior year, with net income and operating cash flow both positive.
Key takeaway
Year ended Dec 31, 2024 · FY2025 10-K
Pfizer Inc. filed its annual report describing a business focused on discovering, developing, and commercializing medicines and vaccines. The filing reports a revenue increase compared to the prior year, with net income and operating cash flow both positive.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$63.6B
Revenue reported for the fiscal year.
Operating income
n/a
Income from operations reported for the year.
Net income
$8B
Net income reported for the year.
Operating cash flow
$12.7B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $73.6B | n/a |
| Dec 31, 2022 | $101.2B | +37.4% |
| Dec 31, 2023 | $59.6B | -41.1% |
| Dec 31, 2024 | $63.6B | +6.8% |
Business overview
Pfizer operates globally in the pharmaceutical industry, with commercial operations, research and development, and collaboration agreements. The company faces competition, pricing pressures, and government regulation, and relies on patents and raw materials. Its business includes international operations and sales and marketing activities.
Financial performance
Revenue increased compared to the prior year, following a decline in the previous period. Net income was positive, and operating cash flow was also positive. The filing does not disclose operating income.
Material risks
The filing includes a dedicated risk factors section, though specific risks are not detailed in the supplied context. General industry risks such as pricing pressures, competition, and government regulation are mentioned in the business overview. The company also notes environmental matters as a risk area.
Liquidity and capital
The company believes it can meet liquidity needs through operating cash flows, financial assets, capital markets access, and credit facilities. It focuses on working capital efficiencies and maintains a conservative investment approach with high-quality, liquid securities.
What to watch
Monitor the next filing for any changes in revenue trend or operating cash flow direction.